Form 4 for INCY Incyte
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-01 · accession 0001209191-22-001661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-05 | 2022-01-01 | INCY | Stamoulis Christiana | EVP, CFO | A - Grant | $0.00 | +14.5K | 57.5K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | A | A | 14,463 | $0.00 | 57,462 | D | — | — | (F1) Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Christiana Stamoulis's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. (F2) Includes an aggregate of 51,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. |